PDPK1 | 3-phosphoinositide dependent protein kinase-1 | Enzymes Plasma proteins
| | | | | Expressed in all |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
PRKCE | Protein kinase C, epsilon | Cancer-related genes Cytoskeleton related proteins Enzymes
| | | | | Expressed in all |
RPS6KB1 | Ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
CAPN10 | Calpain 10 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GHSR | Growth hormone secretagogue receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
GLUD1 | Glutamate dehydrogenase 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GRB14 | Growth factor receptor-bound protein 14 | | | | | | Tissue enhanced |
HADH | Hydroxyacyl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | | | | Group enriched |
IGFBP6 | Insulin-like growth factor binding protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
MYO5A | Myosin VA (heavy chain 12, myoxin) | Disease related genes Plasma proteins
| | | | | Expressed in all |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
TSC2 | Tuberous sclerosis 2 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADIPOR1 | Adiponectin receptor 1 | Predicted membrane proteins
| | | | | Expressed in all |
APPL1 | Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | | | | | | Expressed in all |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins RAS pathway related proteins
| | | | | Expressed in all |
BLK | B lymphoid tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1E | Calcium channel, voltage-dependent, R type, alpha 1E subunit | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
CRIM1 | Cysteine rich transmembrane BMP regulator 1 (chordin-like) | Predicted membrane proteins
| | | | | Expressed in all |
DOK1 | Docking protein 1, 62kDa (downstream of tyrosine kinase 1) | Plasma proteins
| | | | | Expressed in all |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
EIF4EBP2 | Eukaryotic translation initiation factor 4E binding protein 2 | | | | | | Expressed in all |
ENSA | Endosulfine alpha | Plasma proteins
| | | | | Expressed in all |
FAM132A | Family with sequence similarity 132, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins
| | | | | Mixed |
FKBP1B | FK506 binding protein 1B, 12.6 kDa | Enzymes
| | | | | Mixed |
FRS2 | Fibroblast growth factor receptor substrate 2 | | | | | | Expressed in all |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GFPT1 | Glutamine--fructose-6-phosphate transaminase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GRB2 | Growth factor receptor-bound protein 2 | Cancer-related genes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
IGF2BP3 | Insulin-like growth factor 2 mRNA binding protein 3 | | | | | | Tissue enhanced |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
IGFBP7 | Insulin-like growth factor binding protein 7 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
INHBB | Inhibin, beta B | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNG2 | Potassium voltage-gated channel, subfamily G, member 2 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Not detected |
MC4R | Melanocortin 4 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MTOR | Mechanistic target of rapamycin (serine/threonine kinase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |